TSE:3349Consumer Retailing
Assessing COSMOS Pharmaceutical (TSE:3349) Valuation After Sales Growth, Steady Outlook And Higher Dividend
Why COSMOS Pharmaceutical’s latest update matters for shareholders
COSMOS Pharmaceutical (TSE:3349) reported 7.7% sales growth with modest profit gains for the nine months to February 2026, maintained its full year forecast, and flagged an annual dividend increase to ¥75.
See our latest analysis for COSMOS Pharmaceutical.
The latest earnings and dividend news comes after a weaker period for the share price, with a 30 day share price return of 8.34% and a year to date share price return...